Replies to post #7507 on Novavax Inc (NVAX)

[mick]

$NVAX DIS ????? Novavax President Of R&D Dr. Gregory Glenn To Discuss Development Of COVID-19 Vaccines On Panel At 2020 BIO Digital Jun. 9 At 11:30 a.m. PDT
4:10 pm ET June 8, 2020 (Benzinga) Print
GAITHERSBURG, Md., June 08, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ:NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that Gregory M. Glenn, M.D., President of Research and Development, will join other vaccine industry leaders for a panel discussion at 2020 BIO Digital. Taking place on Tuesday, June 9 at 11:30 a.m. EDT, the panel will discuss COVID-19 vaccines. The conversation will consider the complex path from lab to clinical trials, the impact of the evolving science on candidate development and consider how collaboration will bring life-saving vaccines to the world.

Details for the panel are as follows:

Title: “Leveraging Platforms and Partnerships to Develop COVID-19 Vaccines in Record Time”



Date and Time: Tuesday, June 9, 11:30 a.m. PDT



Moderator: Mark McClellan, M.D., Director, Duke Margolis Center for Health Policy



Panelists: Dr. Glenn
Margaret Hamburg, M.D., Foreign Secretary,
National Academy of Medicine
Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation
and Research, United States Food and Drug Administration

Paul Stoffels, M.D., Vice Chairman of the Executive Committee, Chief Scientific Officer, Johnson & Johnson

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.